Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean Gauthier

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Presse Medicale (Paris, France : 1983)|February 13, 2003
[Blood doping and cardiovascular consequences]Jean Gauthier
The Canadian Journal of Urology|February 17, 2001
Absence of human papillomavirus sequences in early stage prostate cancerFred Saad, Kefeng Gu, Johanne Jean-Baptiste, et al.
Journal of Clinical Medicine|March 24, 2019
The New Synthetic Serum-Free Medium OptiPASS Promotes High Proliferation and Drug Efficacy Prediction on Spheroids from MDA-MB-231 and SUM1315 Triple-Negative Breast Cancer Cell LinesClémence Dubois, Pierre Daumar, Corinne Aubel, et al.
Journal of Medicinal Chemistry|December 24, 2004
Non-nucleoside benzimidazole-based allosteric inhibitors of the hepatitis C virus NS5B polymerase: inhibition of subgenomic hepatitis C virus RNA replicons in Huh-7 cellsPierre L Beaulieu, Yves Bousquet, Jean Gauthier, et al.
European Journal of Preventive Cardiology|May 3, 2012
Alterations in echocardiographic and electrocardiographic features in Japanese professional soccer players: comparison to African-Caucasian ethnicitiesGaëlle Kervio, Antonio Pelliccia, Junzo Nagashima, et al.
Cancers|April 30, 2021
The New Serum-Free OptiPASS<sup>®</sup> Medium in Cold and Oxygen-Free Conditions: An Innovative Conservation Method for the Preservation of MDA-MB-231 Triple Negative Breast Cancer SpheroidsAntoine Goisnard, Clémence Dubois, Pierre Daumar, et al.
Sensors (Basel, Switzerland)|March 13, 2024
Lessons Learnt from Monitoring the Etna Volcano Using an IoT Sensor Network through a Period of Intense Eruptive ActivityLaurent Royer, Luca Terray, Maxime Rubéo-Lisa, et al.
The Journal of Biological Chemistry|September 29, 2005
Binding site characterization and resistance to a class of non-nucleoside inhibitors of the hepatitis C virus NS5B polymeraseGeorge Kukolj, Graham A McGibbon, Ginette McKercher, et al.
Cancers|August 27, 2021
LightSpot<sup>®</sup>-FL-1 Fluorescent Probe: An Innovative Tool for Cancer Drug Resistance Analysis by Direct Detection and Quantification of the P-glycoprotein (P-gp) on Monolayer Culture and Spheroid Triple Negative Breast Cancer ModelsAntoine Goisnard, Pierre Daumar, Clémence Dubois, et al.
Bioorganic & Medicinal Chemistry Letters|March 12, 2004
Non-nucleoside inhibitors of the hepatitis C virus NS5B polymerase: discovery of benzimidazole 5-carboxylic amide derivatives with low-nanomolar potencyPierre L Beaulieu, Michael Bös, Yves Bousquet, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Presse Medicale (Paris, France : 1983)|February 13, 2003
[Blood doping and cardiovascular consequences]Jean Gauthier
The Canadian Journal of Urology|February 17, 2001
Absence of human papillomavirus sequences in early stage prostate cancerFred Saad, Kefeng Gu, Johanne Jean-Baptiste, et al.
Journal of Clinical Medicine|March 24, 2019
The New Synthetic Serum-Free Medium OptiPASS Promotes High Proliferation and Drug Efficacy Prediction on Spheroids from MDA-MB-231 and SUM1315 Triple-Negative Breast Cancer Cell LinesClémence Dubois, Pierre Daumar, Corinne Aubel, et al.
Journal of Medicinal Chemistry|December 24, 2004
Non-nucleoside benzimidazole-based allosteric inhibitors of the hepatitis C virus NS5B polymerase: inhibition of subgenomic hepatitis C virus RNA replicons in Huh-7 cellsPierre L Beaulieu, Yves Bousquet, Jean Gauthier, et al.
European Journal of Preventive Cardiology|May 3, 2012
Alterations in echocardiographic and electrocardiographic features in Japanese professional soccer players: comparison to African-Caucasian ethnicitiesGaëlle Kervio, Antonio Pelliccia, Junzo Nagashima, et al.
Cancers|April 30, 2021
The New Serum-Free OptiPASS<sup>®</sup> Medium in Cold and Oxygen-Free Conditions: An Innovative Conservation Method for the Preservation of MDA-MB-231 Triple Negative Breast Cancer SpheroidsAntoine Goisnard, Clémence Dubois, Pierre Daumar, et al.
Sensors (Basel, Switzerland)|March 13, 2024
Lessons Learnt from Monitoring the Etna Volcano Using an IoT Sensor Network through a Period of Intense Eruptive ActivityLaurent Royer, Luca Terray, Maxime Rubéo-Lisa, et al.
The Journal of Biological Chemistry|September 29, 2005
Binding site characterization and resistance to a class of non-nucleoside inhibitors of the hepatitis C virus NS5B polymeraseGeorge Kukolj, Graham A McGibbon, Ginette McKercher, et al.
Cancers|August 27, 2021
LightSpot<sup>®</sup>-FL-1 Fluorescent Probe: An Innovative Tool for Cancer Drug Resistance Analysis by Direct Detection and Quantification of the P-glycoprotein (P-gp) on Monolayer Culture and Spheroid Triple Negative Breast Cancer ModelsAntoine Goisnard, Pierre Daumar, Clémence Dubois, et al.
Bioorganic & Medicinal Chemistry Letters|March 12, 2004
Non-nucleoside inhibitors of the hepatitis C virus NS5B polymerase: discovery of benzimidazole 5-carboxylic amide derivatives with low-nanomolar potencyPierre L Beaulieu, Michael Bös, Yves Bousquet, et al.
Pageof 2